Projects

Cost-benefit analysis is one of the tools commonly used in policy-making: it provides a clear framework for the comparison of the costs and benefits of action (or no-action). Although in some cases a qualitative analysis is sufficient to produce adequate information for a robust conclusion, quantification does bring an added value to the decision making process. 

The costs of an action are usually expressed in monetary values; on the other side, benefits quite often do not have a market value and thus other information is required to attempt monetary valuation through, for example, a benefit transfer. 

Furthermore, when assessing policy initiatives in the chemicals domain, lack of information and uncertainty need to be dealt with at different levels:

  • Mechanisms of action of chemicals on human health and the environment;
  • Routes and levels of exposure, together with the population exposed;
  • Decrease in the levels of exposure obtained by a policy action.

The overall aim of this project is to define a set of indicators for the assessment and monitoring of the human health and environmental benefits delivered by the European legislative framework for chemicals.

Related Services

Related Sectors

Latest News

Imminent decision on the formal amendment of Annex XIV of REACH On 8 December 2016, the EU REACH Committee voted in favour of a draft act proposing the addition of 12 […]
Findings from RPA’S study on human biomonitoring data is published by EFSA Findings from a systematic literature review of available information on HBM of pesticides (or their metabolites) in occupational settings and […]